Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
L'Europe
EU
Mithra Pharmaceuticals SA (MITRA)
Mithra Pharmaceuticals SA (MITRA) Actualités

MITRA

Mithra Pharmaceuticals (MITRA)

Mithra Pharmaceuticals SA

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:EU:MITRA

Date	Heure	Source	Titre	Symbole	Société
03/05/2024	17h30	GlobeNewswire Inc.	Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process	EU:MITRA	Mithra Pharmaceuticals SA
29/04/2024	07h00	GlobeNewswire Inc.	Mithra updates on offers received in the context of its monetization process and on its Annual Report 2023	EU:MITRA	Mithra Pharmaceuticals SA
22/04/2024	07h00	GlobeNewswire Inc.	Mithra secures court protection measures to advance monetization process	EU:MITRA	Mithra Pharmaceuticals SA
08/03/2024	07h00	GlobeNewswire Inc.	Mithra reports full year 2023 financial results	EU:MITRA	Mithra Pharmaceuticals SA
05/03/2024	07h01	GlobeNewswire Inc.	Mithra announces changes to its executive management	EU:MITRA	Mithra Pharmaceuticals SA
05/03/2024	07h00	GlobeNewswire Inc.	Mithra initiates monetization process, receives bridge loan from existing lenders	EU:MITRA	Mithra Pharmaceuticals SA
29/02/2024	11h42	GlobeNewswire Inc.	DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase	EU:MITRA	Mithra Pharmaceuticals SA
15/02/2024	18h23	GlobeNewswire Inc.	Mithra sells shares in Mayne Pharma	EU:MITRA	Mithra Pharmaceuticals SA
06/02/2024	07h00	GlobeNewswire Inc.	Mithra updates on cash position	EU:MITRA	Mithra Pharmaceuticals SA
21/12/2023	17h45	GlobeNewswire Inc.	Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel	EU:MITRA	Mithra Pharmaceuticals SA
20/12/2023	17h45	GlobeNewswire Inc.	Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients	EU:MITRA	Mithra Pharmaceuticals SA
18/12/2023	07h00	GlobeNewswire Inc.	Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial	EU:MITRA	Mithra Pharmaceuticals SA
04/12/2023	07h00	GlobeNewswire Inc.	Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China	EU:MITRA	Mithra Pharmaceuticals SA
30/11/2023	07h00	GlobeNewswire Inc.	Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States	EU:MITRA	Mithra Pharmaceuticals SA
28/11/2023	17h45	GlobeNewswire Inc.	Mithra to hold five presentations on key role of estrogens in women’s health, including Estetrol (E4), at the ESG Congress in Amsterdam	EU:MITRA	Mithra Pharmaceuticals SA
07/11/2023	07h00	GlobeNewswire Inc.	Mithra’s NEXTSTELLIS® granted additional patent in the United States	EU:MITRA	Mithra Pharmaceuticals SA
06/11/2023	18h52	GlobeNewswire Inc.	Mithra releases invitation to its extraordinary securities holders’ meeting	EU:MITRA	Mithra Pharmaceuticals SA
26/10/2023	07h00	GlobeNewswire Inc.	Mithra and Searchlight Pharma sign DONESTA® licensing agreement for Canada	EU:MITRA	Mithra Pharmaceuticals SA
23/10/2023	07h00	GlobeNewswire Inc.	Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement	EU:MITRA	Mithra Pharmaceuticals SA
17/10/2023	07h00	GlobeNewswire Inc.	Mithra’s Board of Directors to propose the removal of its request for change of the remuneration policy at the Special General Meeting	EU:MITRA	Mithra Pharmaceuticals SA
11/10/2023	07h15	GlobeNewswire Inc.	Shareholder Letter	EU:MITRA	Mithra Pharmaceuticals SA
11/10/2023	07h00	GlobeNewswire Inc.	Mithra announces update to the agenda of its upcoming special general shareholders’ meeting	EU:MITRA	Mithra Pharmaceuticals SA
10/10/2023	18h00	GlobeNewswire Inc.	Mithra to Hold Presentations on Key Role of Estrogens in Women’s Health, Including Estetrol (E4), at FIGO World Congress	EU:MITRA	Mithra Pharmaceuticals SA
05/10/2023	07h00	GlobeNewswire Inc.	Mithra Provides an Update in the Context of Recent Market Developments	EU:MITRA	Mithra Pharmaceuticals SA
27/09/2023	07h00	GlobeNewswire Inc.	Mithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen at NAMS 2023	EU:MITRA	Mithra Pharmaceuticals SA
26/09/2023	07h00	GlobeNewswire Inc.	Mithra Financial Results for First-Half 2023	EU:MITRA	Mithra Pharmaceuticals SA
22/09/2023	13h30	GlobeNewswire Inc.	Mithra présentera ses résultats financiers du premier semestre 2023 à ses investisseurs lors d'une conférence web le 26 septembre à 14 h 00 CET	EU:MITRA	Mithra Pharmaceuticals SA
21/09/2023	17h55	GlobeNewswire Inc.	Information on the total number of voting rights (denominator)	EU:MITRA	Mithra Pharmaceuticals SA
21/09/2023	17h55	GlobeNewswire Inc.	Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CEST	EU:MITRA	Mithra Pharmaceuticals SA
12/09/2023	17h45	GlobeNewswire Inc.	Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025	EU:MITRA	Mithra Pharmaceuticals SA

Showing the most relevant articles for your search:EU:MITRA

JP Morgan Chase

Credit Agricole

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales